Orbimed Advisors - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 94 filers reported holding VISTAGEN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$11,811,000
-26.2%
13,421,283
+4.0%
0.21%
-17.7%
Q1 2022$16,008,000
-36.4%
12,909,2830.0%0.26%
-19.8%
Q4 2021$25,173,000
-28.8%
12,909,2830.0%0.32%
-16.7%
Q3 2021$35,371,000
-22.4%
12,909,283
-10.8%
0.39%
-15.6%
Q2 2021$45,574,000
+148.7%
14,467,872
+68.2%
0.46%
+169.6%
Q1 2021$18,327,000
+26.0%
8,604,000
+14.7%
0.17%
+34.6%
Q4 2020$14,550,0007,500,0000.13%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 11,728,033$36,943,00014.76%
VR Adviser, LLC 16,047,286$50,549,0006.13%
COMMODORE CAPITAL LP 3,331,315$10,494,0003.66%
Ghost Tree Capital, LLC 2,000,000$6,300,0001.73%
EPIQ PARTNERS, LLC 932,956$2,939,0001.47%
SPHERA FUNDS MANAGEMENT LTD. 4,080,673$12,854,0000.87%
SILVERARC CAPITAL MANAGEMENT, LLC 615,547$1,939,0000.86%
HighVista Strategies LLC 308,096$971,0000.69%
NEA Management Company, LLC 16,302,596$51,353,0000.67%
Nicholas Investment Partners, LP 2,753,880$8,675,0000.54%
View complete list of VISTAGEN THERAPEUTICS INC shareholders